US OptionsDetailed Quotes

CYTK240719C60000

Watchlist

0.05
-0.08-61.54%

15min DelayClose Jul 19 15:46 ET

0.05High0.03Low

Cytokinetics Stock Discussion

Rocketier

Jun 11 07:25

$Cytokinetics(CYTK.US)$ cmonnn I know u can up alot further! 🚀

Rocketier

May 29 13:05

$Cytokinetics(CYTK.US)$ will there be potential to gain back 100 after the offering?

zulia3003

May 23 09:02

$Cytokinetics(CYTK.US)$ why drop

frankinglily

Apr 1 03:50

Updated Complete & Utter M&A Guesses Purely for Entertainment Purposes:

$SPDR S&P Biotech ETF(XBI.US)$
$Merck & Co(MRK.US)$ x $Immunovant(IMVT.US)$
$Eli Lilly and Co(LLY.US)$ x $Cytokinetics(CYTK.US)$ (and soon)
$Regeneron Pharmaceuticals(REGN.US)$ x $Apellis Pharmaceuticals(APLS.US)$ (panache & brash)
$Gilead Sciences(GILD.US)$ x % $Madrigal Pharmaceuticals(MDGL.US)$ (liver king)
$Bristol-Myers Squibb(BMY.US)$ x $Iovance Biotherapeutics(IOVA.US)$ (cell Tx boost needed)
$Eli Lilly and Co(LLY.US)$ x $Merus(MRUS.US)$ (partner n...

Stoic Trader

Mar 18 11:06

$Cytokinetics(CYTK.US)$ 👀 88.360 testing 🎮 i am in with virtual money lg

Moomoo AI

Mar 11 15:03

CEO's belief in the company's potential to grow independently may have led to a 3% stock dip. Speculation around a Novartis takeover, and its withdrawal, could have swayed investor sentiment.

Cytokinetics Drifts Lower as CEO Touts Standalone Strategy

iamiam

Mar 3 17:29

Sunday Update Mar 3

I'm going to try something new. I'm going to make a Sunday post so that it can be read before the market opens. I hope to still do my update before the market opens on Monday, I always want to see how futures move overnight.
This new thing I'm trying will be some random thoughts about the market. How to use some features on moomoo (a request by some) to do research and develop trading levels. To show this I will introduce some stocks iam in or will be starting positions in.
...

+36

Moomoo has officially landed in Malaysia: Explore, discuss, and win!

Moomoo AI

Feb 5 15:46

Truist analyst Srikripa Devarakonda views the recent weakness in Cytokinetics' stock as a buying opportunity and maintains a buy rating and $86 price target on the stock. Devarakonda continues to see Cytokinetics as a potential M&A target.

Cytokinetics Weakness Buying Oppurtinty, Truist Says

Meltyy

Jan 17 01:34

$SPDR S&P Biotech ETF(XBI.US)$ Jefferies' Yee had a nice report out capturing key JPM comments from large Pharma re: M&A interests. (Summary slide below)
Many thinking $Merck & Co(MRK.US)$ for $Cytokinetics(CYTK.US)$ based on their $15B comment, but $AstraZeneca(AZN.US)$ $Novo-Nordisk A/S(NVO.US)$ mentioned cardiovascular...

Moomoo Recap US

Jan 11 15:43

ColumnsWall Street Today | Stocks Little Changed as Inflation Accelerates

RECAP
Stocks Struggle to Find a Direction
US stocks fluctuated before closing little changed Thursday as investors gauge how the latest data on inflation and jobless claims would influence the path of interest rates in the US.
The $S&P 500 Index(.SPX.US)$ index traded between 4,739.58 and 4,798.50 before ending the day down 0.07%. The $Nasdaq Composite Index(.IXIC.US)$ closed flat while the $Dow Jones Industrial Average(.DJI.US)$ ...

How can ordinary individuals confront the surge in inflation?

No comment yet